SCHEDULE: Joint Filing Agreement for Universe Pharmaceuticals

Origin Force Intelligence Limited and Piao Ye have entered into a joint filing agreement to report beneficial ownership of Universe Pharmaceuticals INC Class A ordinary shares.

Summary

• This filing is a Joint Filing Agreement between Origin Force Intelligence Limited and Piao Ye.
• The agreement allows for the joint filing of a Schedule 13G statement regarding beneficial ownership of Class A ordinary shares of Universe Pharmaceuticals INC.
• Origin Force Intelligence Limited, a British Virgin Islands company, holds 916,759 Class A ordinary shares, representing 18.30% of the class.
• Piao Ye, an individual from Hong Kong, is the sole owner and controller of Origin Force Intelligence Limited.
• The filing date for this agreement is September 1, 2026, with the event requiring the Schedule 13G filing occurring on July 27, 2026.
• The total number of Class A ordinary shares outstanding as of July 27, 2026, was 5,008,313.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative agreement for joint filing of beneficial ownership information, with no new financial or strategic disclosures.

Positives

• Clear disclosure of beneficial ownership for Universe Pharmaceuticals INC Class A ordinary shares.
• Confirmation of a significant stake (18.30%) held by Origin Force Intelligence Limited, controlled by Piao Ye.

Negatives

• No new financial performance data or strategic updates are provided in this filing.
• The filing is purely administrative, related to reporting requirements.

Risks

• Potential for increased scrutiny on beneficial ownership structures if the holding is part of a larger strategy not disclosed.
• Concentration of ownership (18.30%) could indicate potential influence over corporate decisions, though no specific intent is stated.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategy.

Management Comments

• The amount in rows 6, 8 and 9 represents 916,759 Class A ordinary shares held by Origin Force Intelligence Limited, a company with limited liability formed in the British Virgin Islands.
• Origin Force Intelligence Limited is wholly owned and controlled by Piao Ye, an individual.
• Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual holders to report their stakes in publicly traded companies, indicating a passive investment approach. This filing confirms a substantial passive holding in Universe Pharmaceuticals INC.

Stakeholder Impact

• Shareholders: Provides transparency on a significant beneficial owner, potentially influencing market perception.
• Management: May signal a stable or concentrated ownership base, impacting future governance discussions.

Next Steps

• The reporting persons will file a joint Schedule 13G statement detailing their beneficial ownership.
• Ongoing compliance with SEC reporting requirements for beneficial ownership.

Key Dates

Keywords

Universe Pharmaceuticals, Schedule 13G, Beneficial Ownership, Origin Force Intelligence Limited, Piao Ye, Class A ordinary shares, Joint Filing Agreement